Healthcare
1096 companies in this sector
Insider Buys (30d)
111
$46.58M
Insider Sells (30d)
706
$2.36B
Monthly Insider Volume
Industries
Biotechnology618 companies
Medical - Devices129 companies
Drug Manufacturers - Specialty & Generic67 companies
Medical - Diagnostics & Research53 companies
Medical - Instruments & Supplies51 companies
Medical - Healthcare Information Services48 companies
Medical - Care Facilities43 companies
Drug Manufacturers - General22 companies
Medical - Pharmaceuticals20 companies
Medical - Healthcare Plans13 companies
Medical - Equipment & Services13 companies
Medical - Distribution12 companies
Medical - Specialties7 companies
Top Companies by Market Cap
Recent Insider Trades
| Date | Ticker | Company | Insider | Role | Type | Shares | Avg Price | Value |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2026 | STIM | Neuronetics, Inc. | Chernett Jorey | 10 percent owner | Buy | 35,000 | $1.78 | $62.3K |
| Jul 15, 2026 | RDGL | VIVOS INC | Korenko Michael K | director, officer: CEO AND PRESIDENT | Buy | 200,000 | $0.06 | $11.4K |
| Jul 15, 2026 | PHVS | Pharvaris N.V. | Modig Berndt | director, officer: Chief Executive Officer | Sell | 2,292 | $34.97 | $80.2K |
| Jul 15, 2026 | RAPP | Rapport Therapeutics, Inc. Common Stock | Ceesay Abraham | director, officer: Chief Executive Officer | Sell | 8,210 | $40.00 | $328.4K |
| Jul 15, 2026 | SHPH | Shuttle Pharmaceuticals Holdings, Inc. | HRT FINANCIAL LP | 10 percent owner | Sell | 83,149 | $4.48 | $372.7K |
| Jul 15, 2026 | OMDA | Omada Health | Cook Steven L. | officer: Chief Financial Officer | Sell | 5,800 | $24.00 | $139.2K |
| Jul 15, 2026 | VVOS | Vivos Therapeutics, Inc. | Skaff Michael C | 10 percent owner | Buy | 2,749,330 | $0.46 | $1.25M |
| Jul 15, 2026 | BCDA | BioCardia, Inc. | Altman Peter | director, officer: President and CEO | Buy | 4,300 | $0.87 | $3.8K |
| Jul 15, 2026 | OMDA | Omada Health | Gracey Craig | officer: Chief Accounting Officer | Sell | 1,041 | $24.00 | $25.0K |
| Jul 14, 2026 | LQDA | Liquidia Corporation | Kaseta Michael | officer: CFO and COO | Sell | 20,430 | $71.51 | $1.46M |
| Jul 14, 2026 | LQDA | Liquidia Corporation | Saggar Rajeev | officer: Chief Medical Officer | Sell | 9,926 | $71.51 | $709.8K |
| Jul 14, 2026 | LQDA | Liquidia Corporation | JEFFS ROGER | director, officer: Chief Executive Officer | Sell | 35,249 | $71.51 | $2.52M |
| Jul 14, 2026 | PDEX | Pro-Dex, Inc. | Domingo Angelita Rebamontan | director | Sell | 998 | $47.24 | $47.1K |
| Jul 14, 2026 | LQDA | Liquidia Corporation | Adair Jason | officer: Chief Business Officer | Sell | 7,863 | $71.51 | $562.3K |
| Jul 14, 2026 | ALHC | Alignment Healthcare, Inc. | KAO JOHN E | director, officer: Chief Executive Officer | Sell | 298,000 | $19.86 | $5.92M |
| Jul 14, 2026 | FRMM | ETHZilla Corporation | Lomashuk Konstantin | 10 percent owner | Sell | 3,387 | $6.15 | $20.8K |
| Jul 14, 2026 | LQDA | Liquidia Corporation | Krepp Sarah | officer: Chief Human Resource Officer | Sell | 7,864 | $71.51 | $562.4K |
| Jul 14, 2026 | CGON | CG Oncology Inc. | Mulay James | director | Sell | 24,165 | $75.16 | $1.82M |
| Jul 14, 2026 | ARTV | Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | Buy | 21,654 | $8.96 | $194.0K |
| Jul 14, 2026 | ANIP | ANI Pharmaceuticals, Inc. | Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | Sell | 500 | $81.84 | $40.9K |
| Jul 14, 2026 | UTHR | United Therapeutics Corporation | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $535.99 | $5.09M |
| Jul 14, 2026 | BCAX | Bicara Therapeutics Inc. Common Stock | Mazumdar Claire | director, officer: Chief Executive Officer | Sell | 10,000 | $28.42 | $284.2K |
| Jul 14, 2026 | LQDA | Liquidia Corporation | Schundler Russell | officer: General Counsel | Sell | 14,738 | $71.51 | $1.05M |
| Jul 14, 2026 | CYTK | Cytokinetics, Incorporated | Blum Robert I | director, officer: President & CEO | Sell | 7,490 | $82.02 | $614.3K |
| Jul 14, 2026 | FDMT | 4D Molecular Therapeutics, Inc. | Kirn David | director, officer: See Remarks | Sell | 58,333 | $12.64 | $737.4K |
| Jul 14, 2026 | LQDA | Liquidia Corporation | Boyle Dana | officer: Chief Accounting Officer | Sell | 9,002 | $71.51 | $643.7K |
| Jul 14, 2026 | PNTG | The Pennant Group, Inc. | Guerisoli Brent | officer: Chief Executive Officer | Sell | 3,159 | $41.56 | $131.3K |
| Jul 14, 2026 | LQDA | Liquidia Corporation | Khindri Sanjeev | officer: Chief Development Officer | Sell | 1,185 | $71.51 | $84.7K |
| Jul 14, 2026 | IRON | Disc Medicine, Inc. | Quisel John D | director, officer: Chief Executive Officer | Sell | 33,000 | $74.96 | $2.47M |
| Jul 14, 2026 | LQDA | Liquidia Corporation | Moomaw Scott | officer: Chief Commercial Officer | Sell | 9,539 | $71.51 | $682.1K |
| Jul 14, 2026 | HQY | HealthEquity, Inc. | Fiore Michael Henry | officer: EVP, CHIEF COMMERCIAL OFFICER | Sell | 2,354 | $95.00 | $223.6K |
| Jul 13, 2026 | CAI | Caris Life Sciences, Inc. | HALBERT JON | director | Buy | 68,000 | $14.56 | $990.1K |
| Jul 13, 2026 | DNTH | Dianthus Therapeutics, Inc. | Savitz Ryan | officer: EVP, CFO & CBO | Sell | 31,249 | $101.03 | $3.16M |
| Jul 13, 2026 | BBIO | BridgeBio Pharma, Inc. | Ellis Andrea | director | Sell | 17,167 | $84.00 | $1.44M |
| Jul 13, 2026 | BOLD | Boundless Bio, Inc. | TANG KEVIN | 10 percent owner | Buy | 91,585 | $2.42 | $222.1K |
| Jul 13, 2026 | PTCT | PTC Therapeutics, Inc. | Smith Mary L. | director | Sell | 5,834 | $90.00 | $525.1K |
| Jul 13, 2026 | TOI | The Oncology Institute, Inc. | Chernett Jorey | 10 percent owner | Buy | 15,000 | $5.85 | $87.8K |
| Jul 13, 2026 | GKOS | Glaukos Corporation | Thurman Alex R. | officer: SVP & CHIEF FINANCIAL OFFICER | Sell | 10,000 | $155.00 | $1.55M |
| Jul 13, 2026 | INDV | Indivior Pharmaceuticals Inc | Heidbreder Christian | officer: Chief Scientific Officer | Sell | 18,586 | $41.14 | $764.6K |
| Jul 13, 2026 | ADIL | Adial Pharmaceuticals, Inc. | Coastlands Capital LP | 10 percent owner | Buy | 11,753 | $2.78 | $32.6K |
| Jul 13, 2026 | BJDX | Bluejay Diagnostics, Inc. | HRT FINANCIAL LP | 10 percent owner | Sell | 34,938 | $1.40 | $48.9K |
| Jul 13, 2026 | UTHR | United Therapeutics Corporation | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $544.60 | $5.17M |
| Jul 13, 2026 | PRVA | Privia Health Group, Inc. | Mountcastle David | officer: EVP & Chief Financial Officer | Sell | 21,275 | $27.67 | $588.7K |
| Jul 13, 2026 | HTFL | Heartflow, Inc. Common Stock | Farquhar John C.M. | director, officer: Chief Executive Officer | Sell | 22,562 | $27.75 | $626.1K |
| Jul 13, 2026 | TWST | Twist Bioscience Corporation | Laponis Adam | officer: Chief Financial Officer | Sell | 2,399 | $94.33 | $226.3K |
| Jul 13, 2026 | NBIX | Neurocrine Biosciences, Inc. | Lippoldt Darin | officer: Chief Legal Officer | Sell | 10,000 | $179.60 | $1.80M |
| Jul 13, 2026 | BJDX | Bluejay Diagnostics, Inc. | HRT FINANCIAL LP | 10 percent owner | Buy | 64,047 | $1.51 | $96.7K |
| Jul 13, 2026 | BBIO | BridgeBio Pharma, Inc. | Cook Jennifer E. | director | Sell | 148,589 | $88.54 | $13.16M |
| Jul 13, 2026 | NBIX | Neurocrine Biosciences, Inc. | Delaet Ingrid | officer: Chief Regulatory Officer | Sell | 4,367 | $181.02 | $790.5K |
| Jul 13, 2026 | ORKA | Oruka Therapeutics, Inc. | Agarwal Arjun | officer: Senior Vice President, Finance | Sell | 9,699 | $84.67 | $821.3K |
Showing 1–50 of 500
1 / 10
...